Related Experiment Video
Updated: Jul 8, 2026

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
Published on: October 24, 2016
Accessibility to targeted oncology drugs in Slovenia and selected European countries
Mitja Kos1, Marko Obradovic, Ales Mrhar
1Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana, Slovenia. mitja.kos@ffa.uni-lj.si
Aim:
The aim of the study is to compare the accessibility to targeted oncology drugs in Slovenia and selected European countries.
Methods:
Accessibility of targeted oncology drugs was assessed by using their sales data, expressed in mg per individual dying of the cancer for which the drug was indicated.
Results:
The time of introduction of targeted oncology drugs in Slovenia was in most cases similar to the comparison countries, except for alemtuzumab and rituximab. The utilisation of targeted oncology drugs in Slovenia was in most cases lower than in other comparison countries. Ibritumomab had not been used in Slovenia until 2005, similar to France, Switzerland and UK. After 2003 the utilisation of trastuzumab in Slovenia started to rise substantially, approaching the average uptake in comparison countries.
Conclusion:
The utilisation of targeted oncology drugs in Slovenia was in most cases lower than in comparison countries.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Treatment Resistent Cancers
Treatment Resistant Cancers
Drug Products: Biologics, Biosimilars and Interchangeables
